XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.

Abstract

The fact that intron single nucleotide polymorphisms could regulate gene expression or even alter gene expression levels has been the focus of attention. To study the relationship between the intron 11 C/A single nucleotide polymorphism of XPC gene and the efficacy of vinorelbine and cisplatin (NP) chemotherapy, 164 patients with non-small cell lung cancer… (More)
DOI: 10.1097/CAD.0b013e32833ad5aa

Topics

Cite this paper

@article{Zhu2010XPCGI, title={XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.}, author={Li-bo Zhu and Qian Xu and Cheng-yu Hong and Zheng Qin Yue and Ye Zhang and Hui-Nan Ye and Yuan Yuan}, journal={Anti-cancer drugs}, year={2010}, volume={21 7}, pages={669-73} }